|

Chemotherapy drug Clinical Trials

13 actively recruiting trials across 2 locations

Also known as: Bolus Cisplatin, Carboplatin with Paclitaxel, Cisplatin, Non ASCT regimen, Systemic chemotherapy +/- targeted therapy +1 more

Pipeline

Phase 2: 3Phase 3: 3Phase 1/2: 3

Top Sponsors

University Hospital, Strasbourg, France1
University Hospital, Linkoeping1
Tehran University of Medical Sciences1
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation1
Shanghai Chest Hospital1

Indications

Cancer13
Lung Cancer3
Breast Cancer2
Liver Disease1
HLA-A*02:01-positive1

Other11 trials

CIETAI and Sequential Radiotherapy in Squamous Lung Cancer

Phase 2

Clinical Observational Studies:Integrative TCM and Western Medicine for Breast Cancer

Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting

N/A

DEBIRI Plus Chemotherapy vs. Chemotherapy Alone in Colorectal Cancer Liver Metastases

Phase 3

Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.

Evaluation of Metastatic Disease and Oncological Treatment in Patients With Colon Cancer Using Zebra Fish Avatars

Phase 1/2

MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients.

Phase 3

Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer

Phase 3

Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers

Phase 1/2

Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

The Effect of Toripalimab Plus Radiotherapy in Patients With Operable Stage II-IIIA (N+) Non Small Cell Lung Cancer

Phase 2

Duarte, California1 trial

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

City of Hope

Phase 1/2

Boston, Massachusetts1 trial

Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study

Brigham and Women's Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.